RecruitingNCT06541652

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers


Sponsor

Federation Francophone de Cancerologie Digestive

Enrollment

150 participants

Start Date

Mar 26, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational studies aimed at identifying new molecular, histological, circulating and radiological tumor biomarkers, potentially useful at every stage of diagnosis and prognostic or theranostic evaluation.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • years of age or older,
  • with histologically proven hepato-cholangiocarcinoma, fibrolamellar hepatocellular carcinoma, epithelioid hemangioendothelioma or hepatic angiosarcoma
  • diagnosed after January 01, 2018 living or deceased at the time of registration in the cohort
  • for living patients who have not objected to the research: (note of non-objection to be attached° agreeing to participate in ancillary studies must sign the biological consent form for participation in biological studies.

Exclusion Criteria2

  • without social security
  • No access to tumor block

Locations(40)

CHU Amiens picardie

Amiens, France

Chu Angers

Angers, France

Ch - Centresimone Veil de Beauvais

Beauvais, France

Chu Jean Minjoz

Besançon, France

Ch Bethune Beuvry

Béthune, France

Avicenne

Bobigny, France

Cote de Nacre

Caen, France

Centre Hospitalier

Calais, France

Chu de Clichy Hopital Beaujon

Clichy, France

Centre Hospitalier Universitaire Henri Mondor

Créteil, France

CHU

Dijon, France

Chu Grenobles Alpes

La Tronche, France

Centre Hospital Universitaire de lille

Lille, France

Longjumeau Ch Nord Essone

Longjumeau, France

Ch Edouard Herriot

Lyon, France

Centre Léon Berard

Lyon, France

La Clinique de La Sauvegarde

Lyon, France

Chu Edouard Herriot

Lyon, France

Lyon Cac Leon Berard

Lyon, France

Lyon La Croix Rousse

Lyon, France

Hopital Saint Joseph

Marseille, France

Chu de La Timone

Marseille, France

CHR - Metz Thionville Hopital de Mercy

Metz, France

CHU La Source

Orléans, France

Chu de Paris Saint Antoine

Paris, France

AP - HP - Pitié Salpêtrière

Paris, France

PAU CH

Pau, France

Centre Hospitalier de Perpignan

Perpignan, France

Hopital Haut Leveque

Pessac, France

Chu de Poitiers

Poitiers, France

CH - Annecy Genevois

Pringy, France

Chu Robert Debre

Reims, France

CAC - Eugène Marquis

Rennes, France

Ico Site Rene Gauducheau

Saint-Herblain, France

Hopital Nord Chu Saint Etienne

Saint-Priest-en-Jarez, France

Groupe Hospitalier Rance Emeraude

St-Malo, France

Chu Rangueil

Toulouse, France

Chru de Tours

Tours, France

Chu Paul Brousse

Villejuif, France

Gustave Roussy

Villejuif, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06541652


Related Trials